Albis Plastic adds Texin RxT TPU from Covestro to its healthcare product portfolio

ALBIS PLASTIC GmbH, global specialist for the distribution and compounding of technical thermoplastics headquartered in Hamburg, with offices throughout Europe including the UK, expands its healthcare product portfolio by adding Texin® RxT TPU (thermoplastic polyurethane elastomer) types from Covestro AG.

Texin® RxT is particularly well suited to many fields of applications in medical technology, laboratory and diagnostics – such as the production of tubes, catheters, housing parts, soft-touch handles, as well as many other applications.

The material possesses the same mechanical properties as the well-known Desmopan® products from Covestro AG. Particular highlights include its tensile strength, abrasion resistance, elasticity and shock-absorbing properties. Its good resistance to hydrolysis and microbes, chemical resistance and transparence predestine the product for use in the field of healthcare.

Texin® RxT is available in several hardness levels (Shore A70 – D65) and, unlike some conventional rubber or PVC products, does not contain any softeners, which can cause problems such as incompatibilities.

An extensive regulatory service package rounds out the offer. It includes assurance of a consistent formula as well as confirmations of food compatibility as per FDA and biocompatibility e.g. USP Class VI or ISO10993-1.

The corresponding requirements of the European Pharmacopoeia (EP) are also fulfilled. The service package is completed by comprehensive change management to handle any inevitable product changes.

Author
Albis (UK) Ltd

This material is protected by MA Business copyright
See Terms and Conditions.
One-off usage is permitted but bulk copying is not.
For multiple copies contact the sales team.

 

Supporting Information
Do you have any comments about this article?
Name
 
Email
 
Comments
 

Your comments/feedback may be edited prior to publishing. Not all entries will be published.
Please view our Terms and Conditions before leaving a comment.

© MA Business Ltd (a Mark Allen Group Company) 2020